SG/PUT/FRESENIUS/20/0.1/19.12.25 Share Price

Warrant

DE000SU525A1

Market Closed - Boerse Frankfurt Warrants 20:37:07 01/07/2024 BST
0.088 EUR -9.28% Intraday chart for SG/PUT/FRESENIUS/20/0.1/19.12.25
1 month-3.33%
3 months-48.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/07/24 0.088 -9.28%
28/06/24 0.097 +7.78%
27/06/24 0.09 +1.12%
26/06/24 0.089 +1.14%
25/06/24 0.088 +1.15%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 08:37 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SU525A
ISINDE000SU525A1
Date issued 20/12/2023
Strike 20
Maturity 19/12/2025 (536 Days)
Parity 10 : 1
Emission price 0.17
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.18
Lowest since issue 0.075
Delta-0.13x
Omega 3.897
Premium32.58x
Gearing30.76x
Moneyness 0.7067
Difference Strike -8.3
Difference Strike %-41.50%
Spread 0.01
Spread %10.31%
Theoretical value 0.0920
Implied Volatility 34.91 %
Total Loss Probability 76.40 %
Intrinsic value 0.000000
Present value 0.0920
Break even 19.08 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.88 EUR
Average target price
37.26 EUR
Spread / Average Target
+33.63%
Consensus